Gene: THY1
Official Full Name: Thy-1 cell surface antigenprovided by HGNC
Gene Summary: This gene encodes a cell surface glycoprotein and member of the immunoglobulin superfamily of proteins. The encoded protein is involved in cell adhesion and cell communication in numerous cell types, but particularly in cells of the immune and nervous systems. The encoded protein is widely used as a marker for hematopoietic stem cells. This gene may function as a tumor suppressor in nasopharyngeal carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01894 | THY1 Knockout cell line (HeLa) | Human | THY1 | 1:3~1:6 | Negative | Online Inquiry |
KO01895 | THY1 Knockout cell line (A549) | Human | THY1 | 1:3~1:4 | Negative | Online Inquiry |
THY1 Gene Knockout Cell Lines are genetically modified cell models specifically designed to study the role of the THY1 gene, which encodes a glycoprotein involved in various biological processes, including cell adhesion, migration, and signal transduction. These cell lines provide researchers with a powerful tool to investigate the functional consequences of THY1 deficiency and its implications in various physiological and pathological conditions, notably in immune response and cancer biology.
The key mechanism of these cell lines relies on precise gene editing technologies, such as CRISPR-Cas9, which allows for the targeted disruption of the THY1 gene. This knockout approach enables scientists to observe phenotypic alterations, quantify changes in cellular behavior, and delineate downstream signaling pathways, ultimately revealing the gene's contribution to cell biology. Understanding THY1's role can enhance research into immune disorders, fibrosis, and tumor progression, making these cell lines particularly valuable in both basic and applied biomedical science.
In clinical research, THY1 Gene Knockout Cell Lines can facilitate the development of novel therapeutic strategies. For instance, by elucidating the mechanisms by which THY1 influences tumor microenvironments or immune evasion, researchers can devise targeted treatments that enhance patient outcomes. The specificity of these models provides clear advantages over traditional cell lines, enabling more accurate translational research.
One of the unique selling points of our THY1 Gene Knockout Cell Lines is their user-friendly application across a variety of experimental platforms, coupled with strong reproducibility and consistency in results. Unlike alternative methods, these knockout cell lines significantly reduce variability, allowing for clearer data interpretation, which is crucial in the burgeoning field of precision medicine.
Investing in THY1 Gene Knockout Cell Lines enriches research capabilities and accelerates discovery efforts. Researchers and clinicians can leverage these models to gain unprecedented insights into cell biology and disease mechanisms. Our company specializes in creating high-quality genetic models designed to advance scientific research. With a commitment to innovation and precision, we offer unparalleled expertise in developing tools that empower the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.